Division of Pfizer Inc.
Latest From Alacer Corp.
Mentholatum launches new scent for chest rub; Wellmune WGP in four Emergen-C drinks; “revolutionary” digestive supplement; NatureSmart relies on ‘Star Wars’ to win gummy battle; and more new products.
In the first half of 2014 U.S. vitamin product sales have been flat, around 1% to 1.5% monthly growth compared to 6% to 8% in the first half of 2013, according to market research. Factors contributing to the drop include increased competition from fortified foods, imports and specialized product offerings.
FDA cites unapproved OTC combination; pathogenic claims make supplement a drug; Direct Digital supports some claims; Alacer settles false advertising claim for Emergen-C; ScripsAmerica signs deal for RapiMed expansion; and CRN promotes MacKay.
Maves is USP’s development SVP; Pharmavite takes on Toll as sales exec; Lacik shifts to head Reckitt North America; Rainbow Light adds marketing and sales VPs; Lelinski heads Walgreens health and wellness; more People In Brief.
- OTC, Consumer
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Pfizer Inc.
- Senior Management
- Ron Fugate, Pres. & CEO
- Contact Info
Phone: (888) 425-2362
Foothill Ranch, CA 92610
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.